Quality Control Violations Lead to Warning Letter for Brazilian Company

International Pharmaceutical Regulatory Monitor
A A
Violations of quality control standards for finished pharmaceuticals led to an FDA warning letter for Mappel Industria, a Brazil-based company.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor